Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CDGXF stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CDGXF investment potential.

What is CDGXF stock price today?

Get real-time CDGXF stock price, historical data, and price charts on Financhill. Track CDGXF performance with our advanced analysis tools.

Is CDGXF a good investment?

Evaluate CDGXF investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CDGXF stock?

To buy CDGXF stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CDGXF?

View detailed market capitalization data and company valuation metrics for CDGXF on our comprehensive analysis page.

What is the P/E ratio of CDGXF?

Use our fundamental analysis tools to view CDGXF P/E ratio and compare valuation metrics with industry peers.

What are CDGXF earnings?

View CDGXF earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

China Dongxiang (Group) Co. Ltd. 10K Form

Buy

CDGXF
China Dongxiang (Group) Co. Ltd.

Last Price:

$0.05

Seasonality Move:

3.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CDGXF News And Ratings

See the #1 stock for the next 7 days that we like better than CDGXF

CDGXF Financial Statistics

Sales & Book Value

Annual Sales:	$232.8M
Cash Flow:	$0
Price / Cash Flow:	10.02
Annual Sales:	$0.22
Price / Book:	0.12

Profitability

EPS (TTM):	0.00650
Net Income (TTM):	$38M
Gross Margin:	$159.6M
Return on Equity:	2.24%
Return on Assets:	2.07%

China Dongxiang (Group) Co. Ltd. Earnings Forecast

Key China Dongxiang (Group) Co. Ltd. Financial Ratios

The Gross Profit Margin over the past 22 years for CDGXF is 68.58%.
The Selling, General & Administrative Expenses for CDGXF have been equal to 70.49% of Gross Profit Margin.
The Research & Development expenses have been 2.42% of Revenue.
The Interest Expense is 1.04% of Operating Income.
The Net Earning history of CDGXF is 12.32% of Total Revenues.
Per Share Earnings over the last 22 years have been positive in 14 years.

China Dongxiang (Group) Co. Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Textiles, Apparel & Luxury Goods
Sector:	Consumer Discretionary
Current Symbol:	CDGXF
Website:	dxsport.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	7.94
Quick Ratio:	7.44

Price-to-Earnings

Trailing P/E Ratio:	10.2
Forward P/E Ratio:	0

CDGXF Technical Analysis vs Fundamental Analysis

Buy

China Dongxiang (Group) Co. Ltd. (CDGXF) is a Buy

Is China Dongxiang (Group) Co. Ltd. a Buy or a Sell?

China Dongxiang (Group) Co. Ltd. stock is rated a Buy

The current China Dongxiang (Group) Co. Ltd. [CDGXF] share price is $0.05. The Score for CDGXF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.